Exome sequencing of fetal anomaly syndromes: novel phenotype–genotype discoveries

• DOI: 10.1038/s41431-018-0324-y
• Publication Date: 2019-01-24T12:03:29Z
• Authors: Nicole Meier; Elisabeth Bruder; Olav Lapaire; Irene Hoesli; Anjeung Kang; Jürgen Hench; Sylvia Hoeller; Julie De Geyter; Peter Miny; Karl Heinimann; Rabih Chaoui; Sevgi Tercanli; Isabel Filges
• Keywords: 0303 health sciences; Syndrome; Article; 3. Good health; 03 medical and health sciences; Fetus; Phenotype; Mutation; Exome Sequencing; Humans; Abnormalities, Multiple; Exome; Child; Genetic Association Studies

The monogenic etiology of most severe fetal anomaly syndromes is poorly understood. Our objective was to use exome sequencing (ES) to increase our knowledge on causal variants and novel candidate genes associated with specific fetal phenotypes. We employed ES in a cohort of 19 families with one or more fetuses presenting with a distinctive anomaly pattern and/or phenotype recurrence at increased risk for lethal outcomes. Candidate variants were identified in 12 families (63%); in 6 of them a definite diagnosis was achieved including known or novel variants in recognized disease genes (MKS1, OTX2, FGFR2, and RYR1) and variants in novel disease genes describing new fetal phenotypes (CENPF, KIF14). We identified variants likely causal after clinical and functional review (SMAD3, KIF4A, and PIGW) and propose novel candidate genes (PTK7, DNHD1, and TTC28) for early human developmental disease supported by functional and cross-species phenotyping evidence. We describe rare and novel fetal anomaly syndromes and highlight the diagnostic utility of ES, but also its contribution to discovery. The diagnostic yield of the future application of prenatal ES will depend on our ability to increase our knowledge on the specific phenotype-genotype correlations during fetal development.